Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: P&G grants to National Women's Health Network

Executive Summary

P&G grants to National Women's Health Network: NWHN Executive Director Cindy Pearson discloses two grants of less than 3% of the group's total funding during FDA's Endocrinologic & Metabolic Drugs Advisory Committee review of Merck's alendronate. "To Procter & Gamble's credit, the two grants were both made after we had testified against etidronate," Pearson said. P&G gave the advocacy group $7,500 in 1995 and $15,000 in 1996. NWHN appeared at the meeting to suggest that the committee look carefully at the effect of extending the Fosamax patient population on advertising for the product...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS029759

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel